All statements, other than statements of historical fact, contained in this Quarterly Report on Form 10-Q constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.



Forward-looking statements relate to future events or our future financial
performance, and involve known and unknown risks, uncertainties, and other
factors that may cause our actual results, levels of activity, performance or
achievements to be materially different from future results, levels of activity,
performance or achievements expressed or implied by these forward-looking
statements. Factors that could cause actual results to differ materially from
those expressed or implied by the forward-looking statements include, but are
not limited to, the following: our mining and industrial operations; geological
conditions; dependency on a limited number of key production and distribution
facilities and critical equipment; weather conditions; uncertainties in
estimating our economically recoverable reserves and resources; strikes, other
forms of work stoppage or slowdown or other union activities; the inability to
fund necessary capital expenditures or successfully complete capital projects;
supply constraints or price increases for energy and raw materials used in our
production processes; our indebtedness and inability to pay our indebtedness;
restrictions in our debt agreements that may limit our ability to operate our
business or require accelerated debt payments; tax liabilities; the inability of
our customers to access credit or a default by our customers of trade credit
extended by us or financing we have guaranteed; our payment of any dividends;
financial assurance requirements; risks related to the potential phasing out of
LIBOR; the impact of competition on the sales of our products; risks associated
with
                                       21
--------------------------------------------------------------------------------
             Table of Contents          COMPASS MINERALS INTERNATIONAL, 

INC.




our international operations and sales, including changes in currency exchange
rates and inflation risks; increasing costs or a lack of availability of
transportation services, equipment, raw materials or other supplies; the
seasonal demand for our products; the impact of anticipated changes in plant
nutrition product prices and customer application rates; conditions in the
sectors where we sell products and supply and demand imbalances for competing
products; our rights and governmental authorizations to mine and operate our
properties; risks related to unanticipated litigation or investigations or
pending litigation or investigations or other contingencies; compliance with
foreign and United States ("U.S.") laws and regulations related to import and
export requirements and anti-corruption laws; compliance with environmental,
health and safety laws and regulations; environmental liabilities; product
liability claims and product recalls; changes in laws, industry standards and
regulatory requirements; misappropriation or infringement claims relating to
intellectual property; inability to obtain required product registrations or
increased regulatory requirements; the impact of the COVID-19 pandemic, or other
outbreaks of infectious disease or similar public health threats; our ability to
successfully implement our strategies including the timing and outcome of the
potential sale of our Brazil chemical solutions business; plans to develop our
lithium resource, including market entry; the useful life of our mine
properties; our expectation of extending the Goderich mineral lease; conversion
of mineral resources into mineral reserves; risks related to labor shortages and
the loss of key personnel; a compromise of our computer systems, information
technology or operations technology or the inability to protect confidential or
proprietary data; climate change and related laws and regulations; our ability
to expand our business through acquisitions, integrate acquired businesses and
realize anticipated benefits from acquisitions; the impact of Brazil currency
changes on the earn-out consideration we may be entitled to receive with respect
to the sale of our South America specialty plant nutrition business; domestic
and international general business and economic conditions; and other risks
referenced from time to time in this report and our other filings with the
Securities and Exchange Commission (the "SEC"), including Part I, Item 1A, "Risk
Factors" of our Transition Report on Form 10-KT for the transition period
ended September 30, 2021.

In some cases, you can identify forward-looking statements by terminology such
as "may," "might," "will," "should," "could," "expects," "intends," "plans,"
"anticipates," "believes," "estimates," "predicts," "potential," "continue," the
negative of these terms or other comparable terminology. Forward-looking
statements include without limitation statements about our outlook, including
expected sales volumes and prices; existing or potential capital expenditures;
capital projects and investments; the industry and our competition; projected
sources of cash flow; potential legal liability; proposed legislation and
regulatory action; the seasonal distribution of working capital requirements;
our reinvestment of foreign earnings outside the U.S.; payment of future
dividends and ability to reinvest in our business; our ability to optimize cash
accessibility, minimize tax expense and meet debt service requirements; future
tax payments and tax refunds; funding obligations for our United Kingdom
("U.K.") pension plan; outcomes of matters with taxing authorities; the effects
of currency fluctuations and inflation; the seasonality of our business; the
effects of climate change; and the impact of the COVID-19 pandemic on us. These
forward-looking statements are only predictions. Actual events or results may
differ materially.

Although we believe that the expectations reflected in the forward-looking
statements are reasonable, we cannot guarantee future results, levels of
activity, performance or achievements. We undertake no duty to update any of the
forward-looking statements after the date hereof or to reflect the occurrence of
unanticipated events.

Unless the context requires otherwise, references to the "Company," "Compass
Minerals," "our," "us" and "we" refer to Compass Minerals International, Inc.
("CMI," the parent holding company) and its consolidated subsidiaries. Except
where otherwise noted, references to North America include only the continental
U.S. and Canada, and references to the U.K. include only England, Scotland and
Wales. Except where otherwise noted, all references to tons refer to "short
tons" and all amounts are in U.S. dollars. One short ton equals 2,000 pounds.
Compass Minerals and Protassium+ and combinations thereof, are trademarks of CMI
or its subsidiaries in the U.S. and other countries.

Discontinued Operations



During 2020, we initiated an evaluation of the strategic fit of certain of our
businesses. On February 16, 2021, we announced our plan to restructure our
former Plant Nutrition South America segment to enable targeted and separate
sales processes for each portion of the former segment, including our chemicals
and specialty plant nutrition businesses along with our equity method investment
in Fermavi Eletroquímica Ltda. ("Fermavi"). Concurrently, to optimize our asset
base in North America, we evaluated the strategic fit of our North America
micronutrient product business. On March 16, 2021, the Board of the Directors
approved a plan to sell our South America chemicals and specialty plant
nutrition businesses, our investment in Fermavi and our North America
micronutrient product business (collectively, the "Specialty Businesses") with
the goal of reducing our leverage and enabling increased focus on optimizing our
core businesses.

As described further in Item 1, Note 2 to the Consolidated Financial Statements, on March 23, 2021, April 7, 2021 and June 28, 2021, we entered into definitive agreements to sell our South America specialty plant nutrition business, a component of our


                                       22
--------------------------------------------------------------------------------
             Table of Contents          COMPASS MINERALS INTERNATIONAL, 

INC.

North America micronutrient business and our Fermavi investment, respectively.
The South America specialty plant nutrition business sale closed on July 1,
2021, the North America micronutrient sale closed on May 4, 2021, and the sale
of our Fermavi investment closed on August 20, 2021. We continue to actively
pursue the sale of the South America chemicals business, and we believe this
sale is probable to occur within the next twelve months.

We believe there is a single disposal plan representing a strategic shift that
will have a material effect on our operations and financial results.
Consequently, the Specialty Businesses qualify for presentation as assets and
liabilities held for sale and discontinued operations in accordance with U.S.
generally accepted accounting principles ("U.S. GAAP"). Accordingly, current and
noncurrent assets and liabilities of the Specialty Businesses are presented in
the Consolidated Balance Sheets as assets and liabilities held for sale for both
periods presented and their results of operations are presented as discontinued
operations in the Consolidated Statements of Operations for each period
presented.

Fiscal Year



During 2021, we transitioned to a September 30 fiscal year end. The nine-month
period from January 1, 2021 to September 30, 2021, served as a transition
period, and we filed one-time, nine-month transitional financial statements for
the transition period in a Transition Report on Form 10-KT filed with the SEC on
November 30, 2021. Prior to the transition period, our fiscal year was the
calendar year ending on December 31. Our fiscal year 2022 (or "fiscal 2022")
commenced on October 1, 2021 and ends on September 30, 2022.

Critical Accounting Estimates



Preparation of our consolidated financial statements in accordance with U.S.
GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets, liabilities, revenues and expenses. Management
believes the most complex and sensitive judgments result primarily from the need
to make estimates about matters that are inherently uncertain. Part II, Item 7,
"Management's Discussion and Analysis of Financial Condition and Results of
Operations" and Part II, Item 8, Note 2 to the Consolidated Financial Statements
included in our Transition Report on Form 10-KT for the transition period ended
September 30, 2021, describe the significant accounting estimates and policies
used in preparation of our consolidated financial statements. For a further
description of our critical accounting policies, see   Item 1, Note 1   of our
Consolidated Financial Statements included in this Quarterly Report on Form
10-Q. Actual results in these areas could differ from management's estimates.

Company Overview

Compass Minerals is a leading producer of essential minerals, including salt,
sulfate of potash ("SOP") specialty fertilizer and magnesium chloride. As of
December 31, 2021, we operated 12 production and packaging facilities (excluding
3 production facilities in South America that are part of our discontinued
operations), including:
•The largest rock salt mine in the world in Goderich, Ontario, Canada;
•The largest dedicated rock salt mine in the U.K. in Winsford, Cheshire;
•A solar evaporation facility located near Ogden, Utah, which is both the
largest sulfate of potash specialty fertilizer production site and the largest
solar salt production site in the Western Hemisphere; and
•Several mechanical evaporation facilities producing consumer and industrial
salt.

In March 2021, we concluded that certain of our assets met the criteria for
classification as held for sale and discontinued operations. As a result, we are
now presenting two reportable segments in continuing operations, Salt and Plant
Nutrition (which was previously known as the Plant Nutrition North America
segment) in this Form 10-Q. See   Item 1, Note 10   to the Consolidated
Financial Statements for more information. Unless otherwise indicated, the
information and amounts provided in this "Management's Discussion and Analysis
of Financial Condition and Results of Operations" pertain to continuing
operations.

Our Salt segment provides highway deicing salt to customers in North America and
the U.K. as well as consumer deicing and water conditioning products,
ingredients used in consumer and commercial food preparation, and other
salt-based products for consumer, agricultural and industrial applications in
North America. In the U.K., we operate a records management business utilizing
excavated areas of our Winsford salt mine with one other location in London,
England.

Our Plant Nutrition segment produces and markets SOP products in various grades
worldwide to distributors and retailers of crop inputs, as well as growers and
for industrial uses. We market our SOP under the trade name Protassium+.

                                       23
--------------------------------------------------------------------------------
             Table of Contents          COMPASS MINERALS INTERNATIONAL, 

INC.

Consolidated Results of Continuing Operations

The following is a summary of our consolidated results of continuing operations for the three months ended December 31, 2020 and 2021, respectively. The following discussion should be read in conjunction with the information contained in our consolidated financial statements and the notes thereto included in this Quarterly Report on Form 10-Q.


                         THREE MONTHS ENDED DECEMBER 31

[[Image Removed: cmp-20211231_g2.jpg]][[Image Removed: cmp-20211231_g3.jpg]][[Image Removed: cmp-20211231_g4.jpg]][[Image Removed: cmp-20211231_g5.jpg]] * Refer to " -Reconciliation of Net Earnings from Continuing Operations to EBITDA and Adjusted EBITDA " for a reconciliation to the most directly comparable U.S. GAAP financial measure and the reasons we use this non-GAAP measure.

COMMENTARY: THREE MONTHS ENDED DECEMBER 31, 2020 AND 2021




•Total sales increased 7%, or $22.3 million, due to an increase in our Salt
segment, which was partially offset by a decrease in our Plant Nutrition
segment.
•Operating earnings decreased 27%, or $7.7 million, partially due to an increase
in corporate SG&A expenses which include executive transition costs, costs
related to our lithium project and increased legal expenses related to the SEC
investigation and a decrease in our Salt segment's operating earnings. An
increase in Plant Nutrition operating earnings partially offset the decrease in
total operating earnings.
•Earnings before interest, taxes, depreciation and amortization ("EBITDA")*
adjusted for items management believes are not indicative of our ongoing
operating performance ("Adjusted EBITDA")* decreased 6%, or $3.6 million.
•Diluted net loss per share decreased $0.19 to $0.23.

                                       24
--------------------------------------------------------------------------------

             Table of Contents          COMPASS MINERALS INTERNATIONAL, INC.




                         THREE MONTHS ENDED DECEMBER 31

[[Image Removed: cmp-20211231_g6.jpg]][[Image Removed: cmp-20211231_g7.jpg]] COMMENTARY: THREE MONTHS ENDED DECEMBER 31, 2020 AND 2021




Gross Profit: Increased 2%, or $1.4 million; Gross Margin decreased 1 percentage
point to 18%
•Salt segment gross profit decreased $4.2 million primarily due to higher
per-unit logistics and consumer and industrial product costs, which were
partially offset by higher sales volumes.
•The gross profit of the Plant Nutrition segment increased $5.3 million due to
higher average sales prices, which were partially offset by lower sales volumes
and higher per-unit logistics and product costs.

OTHER EXPENSES AND INCOME

COMMENTARY: THREE MONTHS ENDED DECEMBER 31, 2020 AND 2021




SG&A: Increased $9.1 million; increased 2.1 percentage points as a percentage of
sales from 9.8% to 11.9%
•The increase in SG&A expense was primarily due to executive transition costs,
costs related to our lithium project and increased legal expenses related to the
SEC investigation.

Interest Expense: Decreased $1.6 million to $13.9 million •The decrease was primarily due to a decrease in our borrowings outstanding under our credit agreement.



(Gain) Loss on Foreign Exchange: Decreased $6.6 million from a loss of
$6.2 million to a gain of $0.4 million
•We realized foreign exchange gains of $0.4 million in the first quarter of
fiscal 2022 compared to losses of $6.2 million in the same quarter of the prior
fiscal year primarily due to changes in foreign currency exchange rates on our
non U.S. dollar denominated intercompany loans between our U.S. and foreign
subsidiaries.

Other Expense: Increased $0.1 million from $0.1 million to $0.2 million •The increase in other expense is primarily due to our share of losses in the current period related to our equity investments.



Income Tax Benefit: Decreased $7.2 million from $8.4 million to $1.2 million
•Income tax benefit decreased in the first quarter of fiscal 2022 compared to
the same quarter of the prior fiscal year due primarily to the release of
domestic tax reserves in the prior fiscal year exceeding the tax reserves
released in the first quarter of fiscal 2022.
•Our effective tax rate decreased from a benefit of 133% in the prior fiscal
year to a benefit of 18% in the first quarter of fiscal 2022. Our effective tax
rate in the prior fiscal year was impacted by the release of domestic tax
reserves due to statute expirations. Our effective tax rate in the first quarter
of fiscal 2022 was impacted by the release of domestic and foreign tax reserves
due to statute expirations and a shift in the mix of income between the U.S. and
Canada.
•Our income tax provision in both periods differs from the U.S. statutory rate
primarily due to U.S. statutory depletion, state income taxes, nondeductible
executive compensation, foreign income, mining and withholding taxes, executive
compensation and interest expense recognition differences for tax and financial
reporting purposes.

                                       25
--------------------------------------------------------------------------------
             Table of Contents          COMPASS MINERALS INTERNATIONAL, 

INC.




Net (Loss) Earnings from Discontinued Operations: Decreased from income of $13.4
million to loss of $5.5 million
•The net loss from our discontinued operations includes only the results from
our chemical business in South America for the three months ended December 31,
2021, but includes the results of all the South America businesses and the
specialty plant nutrition businesses in the same period of the prior fiscal
year. Refer to   Item 1, Note     2   for additional details.

Operating Segment Performance



The following financial results represent consolidated financial information
with respect to the operations of our Salt and Plant Nutrition segments. The
results of operations of the records management business and other incidental
revenues, include sales of $3.0 million and $2.5 million for the three months
ended December 31, 2021 and 2020, respectively. These revenues are not material
to our consolidated financial results and are not included in the following
operating segment financial data.

                                      Salt

                         THREE MONTHS ENDED DECEMBER 31

                     [[Image Removed: cmp-20211231_g8.jpg]]
                                                         2021          2020
            Salt Sales (in millions)                  $  273.9      $  228.5
            Salt Operating Earnings (in millions)     $   39.4      $   44.5
            Salt Sales Volumes (thousands of tons)
            Highway deicing                              2,807         2,204
            Consumer and industrial                        633           579
            Total tons sold                              3,440         2,783
            Average Salt Sales Price (per ton)
            Highway deicing                           $  58.34      $  59.20
            Consumer and industrial                   $ 174.00      $ 169.30
            Combined                                  $  79.63      $  82.10

COMMENTARY: THREE MONTHS ENDED DECEMBER 31, 2020 AND 2021




•Salt sales increased 20%, or $45.4 million, primarily due to higher Salt sales
volumes.
•Average sales prices decreased 3% due to the higher proportion of highway
deicing salt but contributed $0.5 million to the increase in Salt sales due to
higher average sales prices for consumer and industrial products, which were
offset by lower highway deicing average sales prices.
•Highway deicing average sales prices decreased 1% primarily due to lower North
American highway deicing contract prices for the fiscal 2022 winter season.
Consumer and industrial average sales prices increased 3% due to product sales
mix and an increase in sales prices in the first quarter of 2022 taken to offset
the impact of inflation.
•Salt sales volumes increased 24%, or 657,000 tons, which contributed
$44.9 million to the sales increase. Highway deicing sales volumes increased
27%, primarily as a result of higher commitment volumes for the fiscal 2022
winter season and higher sales volumes in the U.K. in the first quarter of 2022.
Consumer and industrial sales volumes
                                       26
--------------------------------------------------------------------------------
             Table of Contents          COMPASS MINERALS INTERNATIONAL, 

INC.




increased 9%, primarily due to higher deicing sales volumes as the impact of the
COVID-19 pandemic negatively impacted sales volumes in the same period of the
prior fiscal year.
•Salt operating earnings decreased 11%, or $5.1 million, primarily due to higher
per-unit shipping and handling costs, consumer and industrial product costs and
lower average sales prices, partially offset by higher sales volumes. We are
experiencing higher freight costs and inflationary pressures for certain
materials and supplies that were not recovered through increased sales prices
during the period.

                                Plant Nutrition

                         THREE MONTHS ENDED DECEMBER 31

                     [[Image Removed: cmp-20211231_g9.jpg]]
                                                               2021        2020
         Plant Nutrition Sales (in millions)                 $ 54.6      $ 78.2
         Plant Nutrition Operating Earnings (in millions)    $  9.5      $  3.3
         Plant Nutrition Sales Volumes (thousands of tons)       83         143
         Plant Nutrition Average Sales Price (per ton)       $  660      $  548

COMMENTARY: THREE MONTHS ENDED DECEMBER 31, 2020 AND 2021




•Plant Nutrition sales decreased 30%, or $23.6 million due to lower sales
volumes, which were partially offset by higher average sales prices.
•Plant Nutrition sales volumes were lower than the same period of the prior
fiscal year as the prior period volumes were higher than average and feedstock
inconsistencies over the past year have reduced available inventory levels. The
decline in sales volume reduced sales by $32.9 million.
•Plant Nutrition average sales prices increased 20%, which offset the decrease
in sales by $9.3 million.
•Plant Nutrition operating earnings increased $6.2 million to $9.5 million
primarily due to higher average sales prices, which were partially offset by
higher per-unit logistics costs and higher per-unit product costs resulting
primarily from higher energy and other input costs.

Fiscal 2022 Outlook as of December 31, 2021



•We expect Salt segment sales volumes for fiscal 2022 to range from 11.8 million
tons to 12.8 million tons.
•Plant Nutrition segment sales volumes for fiscal 2022 are expected to range
from 280,000 tons to 320,000 tons.
•Fiscal 2022 capital expenditures are expected to be in the $100 million to $110
million range.

Liquidity and Capital Resources



Historically, our cash flows from operating activities have generally been
adequate to fund our basic operating requirements, ongoing debt service and
sustaining investment in our property, plant and equipment. We have also used
cash generated from operations to fund capital expenditures which strengthen our
operational position, pay dividends, fund smaller acquisitions and repay our
debt. To a certain extent, our ability to meet our short- and long-term
liquidity and capital needs is subject to general economic, financial,
competitive, legislative, regulatory and weather conditions, effects of climate
change, geological variations
                                       27
--------------------------------------------------------------------------------
             Table of Contents          COMPASS MINERALS INTERNATIONAL, 

INC.

in our mine deposits and other factors that are beyond our control. Historically, our working capital requirements have been the highest in the first fiscal quarter (ending December 31) and lowest in the third fiscal quarter (ending June 30). When needed, we may fund short-term working capital requirements by accessing our $300 million revolving credit facility.



We have been able to manage our cash flows generated and used across Compass
Minerals to permanently reinvest earnings in our foreign jurisdictions or
efficiently repatriate those funds to the U.S. As of December 31, 2021, we had
$16.4 million of cash and cash equivalents (in our Consolidated Balance Sheets)
that was either held directly or indirectly by foreign subsidiaries. As a result
of U.S. tax reform, we revised our permanently reinvested assertion and we now
expect to repatriate approximately $150 million of unremitted foreign earnings
on which $4.7 million of income tax expense has been recorded for foreign
withholding tax and state income taxes as of December 31, 2021. Additionally, we
changed our permanently reinvested assertion and repatriated $42.5 million of
unremitted foreign earnings from our U.K. operations in September 2021 on which
$0.1 million of income tax expense was recorded during fiscal 2021. Due to our
ability to generate adequate levels of U.S. cash flow on an annual basis, it is
our current intention to continue to reinvest the remaining undistributed
earnings of our foreign subsidiaries indefinitely. We review our tax
circumstances on a regular basis with the intent of optimizing cash
accessibility and minimizing tax expense.

In addition, the amount of permanently reinvested earnings is influenced by,
among other things, the profits generated by our foreign subsidiaries and the
amount of investment in those same subsidiaries. The profits generated by our
U.S. and foreign subsidiaries are impacted by the transfer price charged on the
transfer of our products between them. During fiscal 2018, we reached a
settlement agreement with federal Canadian and U.S. tax authorities on transfer
pricing and management fees as part of an advanced pricing agreement covering
our fiscal 2013-2021 tax years. Canadian provincial taxing authorities continue
to challenge our transfer prices of certain items. The final resolution of these
challenges may not occur for several years. We currently expect the outcome of
these matters will not have a material impact on our results of operations.
However, it is possible the resolution could materially impact the amount of
earnings attributable to our foreign subsidiaries, which could impact the amount
of permanently reinvested foreign earnings. See   Item 1, Note 7   of our
Consolidated Financial Statements for a discussion regarding our Canadian tax
reassessments.

Cash and cash equivalents as of December 31, 2021, of $28.9 million included
cash held by our South America chemical business held for sale of $8.6
million. We used $14.3 million of operating cash flows during the three months
ended December 31, 2021, reflecting increases in our working capital. During the
period ended December 31, 2021, we used cash on hand and availability under our
revolving credit facility and AR securitization to invest $28.2 million in an
equity investment, to fund capital expenditures of $14.5 million and pay
dividends on our common stock of $5.3 million. Cash and cash equivalents from
continuing operations of $20.3 million increased $2.2 million from September 30,
2021. Cash flows used in continuing operations totaled $19.3 million during the
three months ended December 31, 2021, including income from continuing
operations of $7.9 million which included depreciation, depletion and
amortization of $28.3 million, and a net working capital increase of $60.9
million driven by the seasonality of our Salt business. Our working capital
increase primarily reflected the higher level of receivables as of December 31,
2021 compared to September 30, 2021 primarily due to the effect of seasonality
on our Salt business as the higher level of sales during the winter season
begins in the first quarter (ending December 31) of each fiscal year, which
increases our December 31 receivables balance.

As of December 31, 2021, we had $1.01 billion of outstanding indebtedness,
consisting of $250.0 million outstanding under our 4.875% Senior Notes due 2024,
$500.0 million outstanding under our 6.75% Senior Notes due 2027, $205.5 million
of borrowings outstanding under our senior secured credit facilities, consisting
of $77.5 million of term loans and $128.0 million borrowed against our revolving
credit facility), and $59.3 million of outstanding loans under the accounts
receivable financing facility (see   Item 1, Note 8   of our Consolidated
Financial Statements for more detail regarding our debt). Outstanding letters of
credit totaling $13.4 million as of December 31, 2021, reduced available
borrowing capacity under our revolving credit facility to $158.6 million.

On March 23, 2021, we entered into a definitive agreement to sell our South
America specialty plant nutrition business to ICL Brasil Ltda., a subsidiary of
ICL Group Ltd. The transaction closed on July 1, 2021. Upon closing we received
gross proceeds of approximately $421.1 million, following a reduction in
proceeds of $6.2 million in working capital adjustments (finalized during the
quarter ended September 30, 2021), comprised of cash in the amount of
approximately $318.4 million and an additional $102.7 million in net debt
assumed by ICL Brasil Ltd. The terms of the definitive agreement provide for an
additional earn-out payment of up to R$88 million Brazilian reais, payable in
fiscal 2022 and calculated on a sliding scale, if the South America specialty
plant nutrition business achieves certain full-year 2021 EBITDA performance
targets. The Brazilian debt was deducted from gross proceeds from the
transaction.
                                       28
--------------------------------------------------------------------------------

             Table of Contents          COMPASS MINERALS INTERNATIONAL, INC.

On April 7, 2021, we entered into a definitive agreement to sell a component of our North America micronutrient business to Koch Agronomic Services, LLC, a subsidiary of Koch Industries. On May 4, 2021, we completed the sale for approximately $56.7 million and we paid fees totaling $0.5 million.



On June 28, 2021, we entered into a definitive agreement to sell our investment
in Fermavi for R$45 million Brazilian reais (including R$30 million Brazilian
reais of deferred purchase price due in annual installments through August
2025). The transaction closed on August 20, 2021, and we received cash proceeds
of approximately $2.9 million.

We recorded a loss on the sales of the South American specialty plant nutrition
business and investment in Fermavi totaling approximately $209.8 million and a
non-cash impairment loss for the remaining chemical business of approximately
$98.6 million which includes the effect of the significant weakening of the
Brazilian real against the U.S. dollar. These losses were partially offset by
approximately $30.6 million gain from the sale of a component of the North
America micronutrient business.

In July 2021, we utilized cash proceeds from the sales noted above to repay amounts borrowed against our revolving credit facility of $35.0 million. An additional $265.0 million of proceeds was utilized to pay down our term loan balance.



In the quarter ended March 31, 2021, we also made a $41.7 million required
prepayment of our term loan for 2020 Excess Cash Flow (as such term is defined
in the credit agreement). This prepayment, along with the prepayment made in the
last quarter of fiscal 2021 described above, will reduce the future required
term loan payments. As such, we do not have a scheduled term loan payment until
January 2025.

In the future, including in fiscal 2022, we may borrow amounts under the
revolving credit facility or enter into additional financing to fund our working
capital requirements, potential acquisitions and capital expenditures and for
other general corporate purposes.

Our ability to make scheduled interest and principal payments on our
indebtedness, to refinance our indebtedness, to fund planned capital
expenditures and to fund acquisitions will depend on our ability to generate
cash in the future. This, to a certain extent, is subject to general economic,
financial, competitive, legislative, regulatory and other factors that are
beyond our control. Based on our current level of operations, we believe that
cash flow from operations and available cash, together with available borrowings
under our revolving credit facility, will be adequate to meet our liquidity
needs over the next 12 months.

Our debt service obligations could, under certain circumstances, materially
affect our financial condition and prevent us from fulfilling our debt
obligations. As a holding company, CMI's investments in its operating
subsidiaries constitute substantially all of its assets. Consequently, our
subsidiaries conduct substantially all of our consolidated operating activities
and own substantially all of our operating assets. The principal source of the
cash needed to pay our obligations is the cash generated from our subsidiaries'
operations and their borrowings. Our subsidiaries are not obligated to make
funds available to CMI. Furthermore, we must remain in compliance with the terms
of our credit agreement governing our credit facilities, including the total
leverage ratio and interest coverage ratio, in order to pay dividends to our
stockholders. We must also comply with the terms of our indenture governing our
4.875% Senior Notes due July 2024 and our 6.75% Senior Notes due December 2027,
which limit the amount of dividends we can pay to our stockholders. Although we
are in compliance with our debt covenants as of December 31, 2021, we can make
no assurance that we will remain in compliance with these ratios nor can we make
any assurance that the agreements governing the current and future indebtedness
of our subsidiaries will permit our subsidiaries to provide us with sufficient
dividends, distributions or loans to fund scheduled principal or interest
payments on our debt when due. If we consummate an additional acquisition, our
debt service requirements could increase. Furthermore, we may need to refinance
all or a portion of our indebtedness on or before maturity; however, we cannot
provide assurance that we will be able to refinance any of our indebtedness on
commercially reasonable terms or at all.

Principally due to the nature of our deicing business, our cash flows from
operations have historically been seasonal, with the majority of our cash flows
from operations generated during the first half of the calendar year. When we
have not been able to meet our short-term liquidity or capital needs with cash
from operations, whether as a result of the seasonality of our business or other
causes, we have met those needs with borrowings under our revolving credit
facility. We expect to meet the ongoing requirements for debt service, any
declared dividends and capital expenditures from these sources. This, to a
certain extent, is subject to general economic, financial, competitive,
legislative, regulatory and other factors that are beyond our control.

We manage our capital allocation considering our long term strategic objectives
and spending required to sustain our business. We announced on November 15,
2021, that we reduced our dividend by approximately 80% to provide additional
liquidity to
                                       29
--------------------------------------------------------------------------------
             Table of Contents          COMPASS MINERALS INTERNATIONAL, 

INC.




support the business and invest in strategic expansion opportunities. We expect
to reinvest the cash we anticipate retaining from this dividend reduction toward
an expansion of our product portfolio, continued investment in our existing core
assets and other uses. While our equipment and facilities are generally not
impacted by rapid technology changes, our operations require refurbishments and
replacements to maintain structural integrity and reliable production and
shipping capabilities. When possible, we incorporate efficiency, environmental
and safety improvement capabilities into our routine capital projects and we
plan the timing of larger projects to balance with our liquidity and capital
resources. Changes in our operating cash flows may affect our future capital
allocation and spending. For fiscal 2022 we have allocated approximately $15
million of our planned capital spending to upgrade the barge dock at our Cote
Blanche mine and have incorporated efficiency and safety features into the
design. Additionally, we intend to continue to develop our recently identified
lithium resource at our Ogden facility and have allocated approximately $15
million of capital in fiscal 2022 for the construction of a direct lithium
extraction plant. These large projects are expected to be balanced with other
sustaining and efficiency projects totaling approximately $100 to $110 million
in fiscal 2022. We expect to achieve market entry with a lithium product by 2025
and expect significant capital and other expenditures would be required to
achieve this market entry; however, the full amount of this expenditure is
currently unknown and will depend on a number of factors, including the outcome
of our strategic evaluation of development options for our lithium resource. For
more information, refer to Part I, Item 1A, "Risk Factors" in our Form 10-KT for
the for the transition period ended September 30, 2021.

On November 2, 2021, we announced a $45 million equity investment in Fortress
North America, LLC ("Fortress"), building upon a previous $5 million investment.
As of December 31, 2021, we had invested $32 million in Fortress and in January
2022, we invested the remaining $18 million of our planned $50 million
investment bringing our Fortress ownership interest to 45%. Fortress is a
development stage company that intends to achieve commercialization of its
magnesium chloride-based fire-retardant products to help combat wildfires. We
may make further investments in Fortress or make other acquisitions to grow our
business.

The table below provides a summary of our cash flows by category, including cash flows from discontinued operations:

© Edgar Online, source Glimpses